United States · Venture startup

Who invested in GenoMed

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$21Mraised across 2 rounds since 2004, from 2 sources

$21MVenture$389KVenture
Latest round
Venture, $389KJun 2008
Biggest round
$21MVenture · Jul 2004
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2005200620072008
$21MVenture$389KVenture
First round
Venture, $21M
Jul 2004
Biggest round
$21M
Venture · Jul 2004
Between rounds
3.9 years
from the last two

The rounds

  1. Jun 2008
    Venture$389K1 new

    Reported by invest-iq.com

  2. Jul 2004
    Venture$21M1 new
    • Pierpoint Investissements

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2004Venture2008MCIPierpoint Investissements

Everyone who backed them

MCIAngel1round
Pierpoint Investissementsno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about GenoMed

Who invested in GenoMed?

GenoMed's investors include MCI and Pierpoint Investissements.

How much has GenoMed raised?

GenoMed has raised $21M across 2 rounds since 2004.

When did GenoMed last raise?

GenoMed's most recent round was a Venture of $389K in Jun 2008.

What was GenoMed's biggest round?

GenoMed's largest round on record is $21M (Venture), in Jul 2004.

Who backed GenoMed first?

GenoMed's first round on record, in Jul 2004, was backed by Pierpoint Investissements.

What stage is GenoMed at?

GenoMed's latest named round is a Venture, in Jun 2008.

Where is GenoMed based?

GenoMed is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.